ZA200309043B - Process for the production of quinazolines. - Google Patents

Process for the production of quinazolines. Download PDF

Info

Publication number: ZA200309043B
Authority: ZA; South Africa
Prior art keywords: formula; compound; reaction; ring; alkyl
Prior art date: 2001-08-01

Application number

ZA200309043A

Other languages

English (en)

Inventor

Boulton Lee Terence

Crook Robert James

Pettman Alan John

Robert Walton

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-01

Filing date

2003-11-20

Publication date

2004-11-22

2003-11-20 Application filed by Pfizer filed Critical Pfizer

2004-11-22 Publication of ZA200309043B publication Critical patent/ZA200309043B/en

Links

238000000034 method Methods 0.000 title claims description 49
238000004519 manufacturing process Methods 0.000 title claims description 11
150000003246 quinazolines Chemical class 0.000 title description 6
150000001875 compounds Chemical class 0.000 claims description 53
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 38
238000006243 chemical reaction Methods 0.000 claims description 29
125000000217 alkyl group Chemical group 0.000 claims description 17
-1 alkali metal alkoxide Chemical class 0.000 claims description 16
125000005842 heteroatom Chemical group 0.000 claims description 16
229910052760 oxygen Inorganic materials 0.000 claims description 16
229910052717 sulfur Inorganic materials 0.000 claims description 16
125000002373 5 membered heterocyclic group Chemical group 0.000 claims description 14
125000004070 6 membered heterocyclic group Chemical group 0.000 claims description 14
125000003545 alkoxy group Chemical group 0.000 claims description 14
239000002585 base Substances 0.000 claims description 14
IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 14
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 12
125000004122 cyclic group Chemical group 0.000 claims description 11
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 9
229910052757 nitrogen Inorganic materials 0.000 claims description 9
QHJVAZDEOBKUGE-UHFFFAOYSA-N 6-amino-3,4-dimethoxy-2-pyridin-2-ylbenzonitrile Chemical group COC1=CC(N)=C(C#N)C(C=2N=CC=CC=2)=C1OC QHJVAZDEOBKUGE-UHFFFAOYSA-N 0.000 claims description 8
229910052736 halogen Inorganic materials 0.000 claims description 8
150000002367 halogens Chemical class 0.000 claims description 8
125000004433 nitrogen atom Chemical group N* 0.000 claims description 8
150000003839 salts Chemical class 0.000 claims description 8
JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical group CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 7
125000001153 fluoro group Chemical group F* 0.000 claims description 6
239000003880 polar aprotic solvent Substances 0.000 claims description 6
239000012453 solvate Substances 0.000 claims description 6
ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 claims description 5
239000003054 catalyst Substances 0.000 claims description 5
125000004430 oxygen atom Chemical group O* 0.000 claims description 5
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 5
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 5
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 4
UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 4
MTAXDWONEJVCNF-UHFFFAOYSA-N n-(2-cyano-3,4-dihydro-1h-isoquinolin-5-yl)methanesulfonamide Chemical group C1N(C#N)CCC2=C1C=CC=C2NS(=O)(=O)C MTAXDWONEJVCNF-UHFFFAOYSA-N 0.000 claims description 4
229910052708 sodium Inorganic materials 0.000 claims description 4
239000011734 sodium Substances 0.000 claims description 4
125000001963 4 membered heterocyclic group Chemical group 0.000 claims description 3
125000003341 7 membered heterocyclic group Chemical group 0.000 claims description 3
150000001412 amines Chemical class 0.000 claims description 3
ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 claims description 3
229910052740 iodine Inorganic materials 0.000 claims description 3
125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
239000002253 acid Substances 0.000 claims description 2
229910052783 alkali metal Inorganic materials 0.000 claims description 2
229910052784 alkaline earth metal Inorganic materials 0.000 claims description 2
125000003118 aryl group Chemical group 0.000 claims description 2
150000001555 benzenes Chemical class 0.000 claims description 2
125000000623 heterocyclic group Chemical group 0.000 claims description 2
239000011630 iodine Substances 0.000 claims description 2
150000003222 pyridines Chemical class 0.000 claims description 2
229920006395 saturated elastomer Polymers 0.000 claims description 2
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 2
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 19
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 19
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 17
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
239000000243 solution Substances 0.000 description 14
239000000203 mixture Substances 0.000 description 13
238000002360 preparation method Methods 0.000 description 11
239000007787 solid Substances 0.000 description 10
239000000725 suspension Substances 0.000 description 10
MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 7
235000019439 ethyl acetate Nutrition 0.000 description 7
239000002002 slurry Substances 0.000 description 7
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical group CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 6
229940011051 isopropyl acetate Drugs 0.000 description 6
GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 6
238000010992 reflux Methods 0.000 description 6
OJPDDQSCZGTACX-UHFFFAOYSA-N 2-[n-(2-hydroxyethyl)anilino]ethanol Chemical compound OCCN(CCO)C1=CC=CC=C1 OJPDDQSCZGTACX-UHFFFAOYSA-N 0.000 description 5
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 5
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
239000008346 aqueous phase Substances 0.000 description 4
KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 description 4
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical group [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
239000011541 reaction mixture Substances 0.000 description 4
RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
IMRWILPUOVGIMU-UHFFFAOYSA-N 2-bromopyridine Chemical compound BrC1=CC=CC=N1 IMRWILPUOVGIMU-UHFFFAOYSA-N 0.000 description 3
LFSYMBZTFIVRSE-UHFFFAOYSA-N 6-amino-2-iodo-3,4-dimethoxybenzonitrile Chemical compound COC1=CC(N)=C(C#N)C(I)=C1OC LFSYMBZTFIVRSE-UHFFFAOYSA-N 0.000 description 3
SMWDFEZZVXVKRB-UHFFFAOYSA-N anhydrous quinoline Natural products N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 3
229910002091 carbon monoxide Inorganic materials 0.000 description 3
GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 3
229910052744 lithium Inorganic materials 0.000 description 3
OLYXPBZBZBVRGD-UHFFFAOYSA-N n-[2-(4-amino-6,7-dimethoxy-5-pyridin-2-ylquinazolin-2-yl)-3,4-dihydro-1h-isoquinolin-5-yl]methanesulfonamide Chemical compound COC=1C(OC)=CC2=NC(N3CC4=C(C(=CC=C4)NS(C)(=O)=O)CC3)=NC(N)=C2C=1C1=CC=CC=N1 OLYXPBZBZBVRGD-UHFFFAOYSA-N 0.000 description 3
125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 3
125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 description 3
ZVCDLGYNFYZZOK-UHFFFAOYSA-M sodium cyanate Chemical compound [Na]OC#N ZVCDLGYNFYZZOK-UHFFFAOYSA-M 0.000 description 3
239000002904 solvent Substances 0.000 description 3
NHDIQVFFNDKAQU-UHFFFAOYSA-N tripropan-2-yl borate Chemical compound CC(C)OB(OC(C)C)OC(C)C NHDIQVFFNDKAQU-UHFFFAOYSA-N 0.000 description 3
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
206010004446 Benign prostatic hyperplasia Diseases 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
OHXAXIZDJLLTQF-UHFFFAOYSA-N OBOC1=CC=CC=N1 Chemical compound OBOC1=CC=CC=N1 OHXAXIZDJLLTQF-UHFFFAOYSA-N 0.000 description 2
208000004403 Prostatic Hyperplasia Diseases 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
239000012455 biphasic mixture Substances 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
238000005859 coupling reaction Methods 0.000 description 2
239000012043 crude product Substances 0.000 description 2
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 2
239000000463 material Substances 0.000 description 2
QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
239000012074 organic phase Substances 0.000 description 2
NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
229910000027 potassium carbonate Inorganic materials 0.000 description 2
JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 2
CGRKYEALWSRNJS-UHFFFAOYSA-N sodium;2-methylbutan-2-olate Chemical compound [Na+].CCC(C)(C)[O-] CGRKYEALWSRNJS-UHFFFAOYSA-N 0.000 description 2
HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
GYUURHMITDQTRU-UHFFFAOYSA-N tributyl(pyridin-2-yl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C1=CC=CC=N1 GYUURHMITDQTRU-UHFFFAOYSA-N 0.000 description 2
KRIWIRSMQRQYJG-DLBZAZTESA-N (2s,3s)-3-[[7-(benzylamino)-3-propan-2-ylpyrazolo[1,5-a]pyrimidin-5-yl]amino]butane-1,2,4-triol Chemical compound C=1C(N[C@@H](CO)[C@H](O)CO)=NC2=C(C(C)C)C=NN2C=1NCC1=CC=CC=C1 KRIWIRSMQRQYJG-DLBZAZTESA-N 0.000 description 1
BHKKSKOHRFHHIN-MRVPVSSYSA-N 1-[[2-[(1R)-1-aminoethyl]-4-chlorophenyl]methyl]-2-sulfanylidene-5H-pyrrolo[3,2-d]pyrimidin-4-one Chemical compound N[C@H](C)C1=C(CN2C(NC(C3=C2C=CN3)=O)=S)C=CC(=C1)Cl BHKKSKOHRFHHIN-MRVPVSSYSA-N 0.000 description 1
HMQKXPNXTCBNRI-UHFFFAOYSA-N 2-[n-(2-hydroxyethyl)anilino]ethanol;pyridin-2-ylboronic acid Chemical compound OB(O)C1=CC=CC=N1.OCCN(CCO)C1=CC=CC=C1 HMQKXPNXTCBNRI-UHFFFAOYSA-N 0.000 description 1
MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 1
OCKGFTQIICXDQW-ZEQRLZLVSA-N 5-[(1r)-1-hydroxy-2-[4-[(2r)-2-hydroxy-2-(4-methyl-1-oxo-3h-2-benzofuran-5-yl)ethyl]piperazin-1-yl]ethyl]-4-methyl-3h-2-benzofuran-1-one Chemical compound C1=C2C(=O)OCC2=C(C)C([C@@H](O)CN2CCN(CC2)C[C@H](O)C2=CC=C3C(=O)OCC3=C2C)=C1 OCKGFTQIICXDQW-ZEQRLZLVSA-N 0.000 description 1
239000012359 Methanesulfonyl chloride Substances 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
CQODGVQBRIGKLJ-UHFFFAOYSA-L [Na+].[Na+].[O-]OOO[O-] Chemical compound [Na+].[Na+].[O-]OOO[O-] CQODGVQBRIGKLJ-UHFFFAOYSA-L 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000002411 adverse Effects 0.000 description 1
229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
150000008041 alkali metal carbonates Chemical class 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
244000309464 bull Species 0.000 description 1
238000009833 condensation Methods 0.000 description 1
230000005494 condensation Effects 0.000 description 1
125000000753 cycloalkyl group Chemical group 0.000 description 1
QLBHNVFOQLIYTH-UHFFFAOYSA-L dipotassium;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [K+].[K+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O QLBHNVFOQLIYTH-UHFFFAOYSA-L 0.000 description 1
230000000694 effects Effects 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
239000000284 extract Substances 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
239000012634 fragment Substances 0.000 description 1
125000002541 furyl group Chemical group 0.000 description 1
231100001261 hazardous Toxicity 0.000 description 1
239000000383 hazardous chemical Substances 0.000 description 1
230000017525 heat dissipation Effects 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
229910010272 inorganic material Inorganic materials 0.000 description 1
239000011147 inorganic material Substances 0.000 description 1
125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
125000005956 isoquinolyl group Chemical group 0.000 description 1
125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 1
QBXFQTLJZAJJQN-UHFFFAOYSA-N n-(1,2,3,4-tetrahydroisoquinolin-5-yl)methanesulfonamide Chemical compound C1NCCC2=C1C=CC=C2NS(=O)(=O)C QBXFQTLJZAJJQN-UHFFFAOYSA-N 0.000 description 1
VIXRVBRUSDQWJD-UHFFFAOYSA-N n-(1,2,3,4-tetrahydroisoquinolin-5-yl)methanesulfonamide;hydrochloride Chemical compound Cl.C1NCCC2=C1C=CC=C2NS(=O)(=O)C VIXRVBRUSDQWJD-UHFFFAOYSA-N 0.000 description 1
125000002971 oxazolyl group Chemical group 0.000 description 1
229910052763 palladium Inorganic materials 0.000 description 1
YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 1
229960005235 piperonyl butoxide Drugs 0.000 description 1
231100000572 poisoning Toxicity 0.000 description 1
230000000607 poisoning effect Effects 0.000 description 1
230000002028 premature Effects 0.000 description 1
239000000047 product Substances 0.000 description 1
125000004076 pyridyl group Chemical group 0.000 description 1
125000000714 pyrimidinyl group Chemical group 0.000 description 1
CZAAKPFIWJXPQT-UHFFFAOYSA-N quinazolin-2-amine Chemical class C1=CC=CC2=NC(N)=NC=C21 CZAAKPFIWJXPQT-UHFFFAOYSA-N 0.000 description 1
239000000376 reactant Substances 0.000 description 1
239000012429 reaction media Substances 0.000 description 1
238000001953 recrystallisation Methods 0.000 description 1
238000006748 scratching Methods 0.000 description 1
230000002393 scratching effect Effects 0.000 description 1
238000007086 side reaction Methods 0.000 description 1
JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 1
238000003756 stirring Methods 0.000 description 1
239000001117 sulphuric acid Substances 0.000 description 1
235000011149 sulphuric acid Nutrition 0.000 description 1
150000003526 tetrahydroisoquinolines Chemical group 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
125000001544 thienyl group Chemical group 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Urology & Nephrology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyridine Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

ZA200309043A 2001-08-01 2003-11-20 Process for the production of quinazolines. ZA200309043B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0118752.5A GB0118752D0 (en)	2001-08-01	2001-08-01	Process for the production of quinazolines

Publications (1)

Publication Number	Publication Date
ZA200309043B true ZA200309043B (en)	2004-11-22

Family

ID=9919612

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200309043A ZA200309043B (en)	2001-08-01	2003-11-20	Process for the production of quinazolines.

Country Status (27)

Country	Link
US (1)	US7026479B2 (cs)
EP (1)	EP1412331B1 (cs)
JP (1)	JP2005501054A (cs)
KR (1)	KR20040019097A (cs)
CN (1)	CN1533378A (cs)
AP (1)	AP1299A (cs)
AR (1)	AR036204A1 (cs)
AT (1)	ATE323677T1 (cs)
BR (1)	BR0211670A (cs)
CA (1)	CA2451075A1 (cs)
CZ (1)	CZ2004151A3 (cs)
DE (1)	DE60210778T2 (cs)
DO (1)	DOP2002000443A (cs)
EG (1)	EG23204A (cs)
ES (1)	ES2260457T3 (cs)
GB (1)	GB0118752D0 (cs)
HN (1)	HN2002000197A (cs)
HU (1)	HUP0401573A3 (cs)
IL (1)	IL158998A0 (cs)
MX (1)	MXPA04000978A (cs)
PA (1)	PA8550301A1 (cs)
PE (1)	PE20030346A1 (cs)
PL (1)	PL368520A1 (cs)
RU (1)	RU2261861C1 (cs)
UY (1)	UY27399A1 (cs)
WO (1)	WO2003011829A1 (cs)
ZA (1)	ZA200309043B (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2280003B1 (en)	2002-07-15	2014-04-02	Symphony Evolution, Inc.	Process for preparing receptor-type kinase modulators
PT2213661E (pt)	2003-09-26	2011-12-15	Exelixis Inc	Moduladores de c-met e métodos de uso
CN1972688B (zh) *	2004-05-06	2012-06-27	沃尼尔·朗伯有限责任公司	4-苯胺基-喹唑啉-6-基-酰胺类化合物
KR20090047450A (ko) *	2006-08-04	2009-05-12	메르츠 파마 게엠베하 운트 코. 카가아	치환된 피라졸로피리미딘, 이의 제조 방법 및 의약품으로서의 이의 용도
SG173014A1 (en)	2009-01-16	2011-08-29	Exelixis Inc	Malate salt of n- (4- { [ 6, 7-bis (methyloxy) quin0lin-4-yl] oxy}phenyl)-n' - (4 -fluorophenyl) cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer
NZ755378A (en)	2009-03-18	2022-07-29	Resverlogix Corp	Novel quinazolinones and related compounds for use as anti-inflammatory agents
IN2012DN00352A (cs) *	2009-06-16	2015-08-21	Bikam Pharmaceuticals Inc
UA108618C2 (uk)	2009-08-07	2015-05-25		Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку
AU2012346214B2 (en)	2011-11-30	2017-09-14	Bikam Pharmaceuticals, Inc.	Opsin-binding ligands, compositions and methods of use
RS56846B1 (sr) *	2012-10-15	2018-04-30	Resverlogix Corp	Jedinjenja korisna za sintezu jedinjenja benzamida
JO3789B1 (ar)	2015-03-13	2021-01-31	Resverlogix Corp	التراكيب والوسائل العلاجية المعتمدة لمعالجة الامراض المتعلقة بالمتممة

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8719378D0 (en) *	1987-08-15	1987-09-23	Pfizer Ltd	Antiarrythmic agents
EP0894797A4 (en) *	1997-01-09	2001-08-16	Terumo Corp	NEW AMID DERIVATIVES AND INTERMEDIATES ON YOUR SYNTHESIS
GB9700504D0 (en) *	1997-01-11	1997-02-26	Pfizer Ltd	Pharmaceutical compounds

2001
- 2001-08-01 GB GBGB0118752.5A patent/GB0118752D0/en not_active Ceased
2002
- 2002-07-11 PA PA20028550301A patent/PA8550301A1/es unknown
- 2002-07-19 DE DE60210778T patent/DE60210778T2/de not_active Expired - Fee Related
- 2002-07-19 RU RU2004102692/04A patent/RU2261861C1/ru not_active IP Right Cessation
- 2002-07-19 KR KR10-2004-7001513A patent/KR20040019097A/ko not_active Ceased
- 2002-07-19 MX MXPA04000978A patent/MXPA04000978A/es active IP Right Grant
- 2002-07-19 WO PCT/IB2002/002872 patent/WO2003011829A1/en not_active Ceased
- 2002-07-19 ES ES02745749T patent/ES2260457T3/es not_active Expired - Lifetime
- 2002-07-19 CZ CZ2004151A patent/CZ2004151A3/cs unknown
- 2002-07-19 BR BR0211670-7A patent/BR0211670A/pt not_active IP Right Cessation
- 2002-07-19 CA CA002451075A patent/CA2451075A1/en not_active Abandoned
- 2002-07-19 EP EP02745749A patent/EP1412331B1/en not_active Expired - Lifetime
- 2002-07-19 JP JP2003517021A patent/JP2005501054A/ja active Pending
- 2002-07-19 CN CNA028143256A patent/CN1533378A/zh active Pending
- 2002-07-19 AT AT02745749T patent/ATE323677T1/de not_active IP Right Cessation
- 2002-07-19 US US10/199,755 patent/US7026479B2/en not_active Expired - Fee Related
- 2002-07-19 HU HU0401573A patent/HUP0401573A3/hu unknown
- 2002-07-19 IL IL15899802A patent/IL158998A0/xx unknown
- 2002-07-19 PL PL02368520A patent/PL368520A1/xx not_active Application Discontinuation
- 2002-07-23 DO DO2002000443A patent/DOP2002000443A/es unknown
- 2002-07-26 PE PE2002000678A patent/PE20030346A1/es not_active Application Discontinuation
- 2002-07-29 HN HN2002000197A patent/HN2002000197A/es unknown
- 2002-07-29 UY UY27399A patent/UY27399A1/es not_active Application Discontinuation
- 2002-07-29 EG EG2002070853A patent/EG23204A/xx active
- 2002-07-31 AR ARP020102914A patent/AR036204A1/es unknown
- 2002-08-01 AP APAP/P/2002/002602A patent/AP1299A/en active
2003
- 2003-11-20 ZA ZA200309043A patent/ZA200309043B/en unknown

Also Published As

Publication number	Publication date
CZ2004151A3 (cs)	2005-01-12
DE60210778T2 (de)	2007-01-04
HUP0401573A3 (en)	2005-06-28
PL368520A1 (en)	2005-04-04
UY27399A1 (es)	2003-02-28
WO2003011829A1 (en)	2003-02-13
JP2005501054A (ja)	2005-01-13
AP2002002602A0 (en)	2002-09-30
ES2260457T3 (es)	2006-11-01
DOP2002000443A (es)	2003-02-15
EP1412331A1 (en)	2004-04-28
EG23204A (en)	2004-07-31
ATE323677T1 (de)	2006-05-15
PE20030346A1 (es)	2003-04-05
RU2004102692A (ru)	2005-07-10
MXPA04000978A (es)	2004-04-20
AR036204A1 (es)	2004-08-18
BR0211670A (pt)	2004-07-13
RU2261861C1 (ru)	2005-10-10
US7026479B2 (en)	2006-04-11
CA2451075A1 (en)	2003-02-13
EP1412331B1 (en)	2006-04-19
AP1299A (en)	2004-09-06
KR20040019097A (ko)	2004-03-04
DE60210778D1 (de)	2006-05-24
CN1533378A (zh)	2004-09-29
IL158998A0 (en)	2004-05-12
US20030100753A1 (en)	2003-05-29
GB0118752D0 (en)	2001-09-26
HN2002000197A (es)	2003-02-27
PA8550301A1 (es)	2003-09-05
HUP0401573A2 (hu)	2005-01-28

Publication	Publication Date	Title
US5474996A (en)	1995-12-12	Pyrimidine derivatives
EP3596078B1 (en)	2023-04-12	Fused pentacyclic imidazole derivatives as modulators of tnf activity
ZA200309043B (en)	2004-11-22	Process for the production of quinazolines.
AU2005300311A1 (en)	2006-05-11	Methods for preparing indazole compounds
EP1140933B1 (en)	2004-09-08	Process for preparing n6-substituted deaza-adenosine derivatives
CN115594678B (zh)	2024-11-15	含氮多环稠环类化合物的制备方法及其中间体和用途
JP2008501764A (ja)	2008-01-24	４−フェニル−ピリミジン−２−カルボニトリル誘導体
AU2002317442A1 (en)	2003-02-17	Process for the production of quinazolines
JPH107662A (ja)	1998-01-13	非対称性４，６−ビス（アリールオキシ）ピリミジン化合物の製造方法
KR20020062363A (ko)	2002-07-25	4-(헤테로아릴-메틸)-할로겐-1(2ｈ)-프탈라지논의 제조 방법
JPH0774205B2 (ja)	1995-08-09	新規イミダゾ−ル誘導体
CN117682986A (zh)	2024-03-12	一种β-吡啶酮衍生物的合成方法
US6734303B2 (en)	2004-05-11	Process for the production of quinazolines
EP1387839B1 (en)	2006-03-08	Process for the production of quinazolines
SK13582001A3 (sk)	2003-02-04	Spôsob prípravy kyseliny 3S-3-amino-3-arylpropiónovej a jej derivátov
JPH04243875A (ja)	1992-08-31	２−フェニル−６−（ピリミジン−２−イル）ピリジン化合物の製造方法、中間体化合物及び中間体化合物の製造方法
JP2001081074A (ja)	2001-03-27	アリールピリジン誘導体の製造法
WO2017031215A1 (en)	2017-02-23	Process development of a pyridine-containing nk-1 receptor antagonist
UA54479C2 (uk)	2003-03-17	СПОСІБ ОДЕРЖАННЯ [(1S)-[1<font face="Symbol">a</font>,2<font face="Symbol">b</font>,3<font face="Symbol">b</font>,4<font face="Symbol">a</font>(S*)]]-4-[7-[[1-(3-ХЛОР-2-ТІЄНІЛ)МЕТИЛ] ПРОПІЛ]АМІНО]-3Н-ІМІДАЗО[4,5-B]ПІРИДИН-3-ІЛ]-N-ЕТИЛ-2,3-ДИГІДРОКСИЦИКЛОПЕНТАНКАРБОКСАМІДУ, СПОСОБИ ОДЕРЖАННЯ ПРОМІЖНИХ СПОЛУК ДЛЯ ЙОГО ОДЕРЖАННЯ ТА ПРОМІЖНІ СПОЛУКИ
AU2005284826A1 (en)	2006-03-23	Process for the preparation of 6, 8-substituted `1, 7 naphthpyridin derivatives by reacting the 8-halo-`1, 7 naphthpyridin-derivate with an organic boronic acid derivatives and intermediates of this process
CZ20001040A3 (cs)	2000-08-16	Způsoby a meziprodukty pro přípravu antifolátů
JP2001508410A (ja)	2001-06-26	ヒドロキシ複素環式芳香族化合物のアリールアミンへの変換方法
HK1040239B (en)	2005-04-22	Process for preparing n6-substituted deaza-adenosine derivatives
JPH08165282A (ja)	1996-06-25	２−アルキル−４−オキソ−５、６、７、８−テトラヒドロ−シクロヘプトイミダゾ−ルの製造方法